ATOH8 is a basic helix-loop-helix (bHLH) transcription factor that functions as both a transcriptional activator and repressor in development and disease 1. As a transcription factor, ATOH8 binds DNA at E-box elements and regulates gene expression through multiple mechanisms 1. In cellular senescence, ATOH8 binds SMAD3 to form a transcriptional complex that directly represses cell cycle-promoting genes, thereby preventing Ras-driven malignant transformation in lung epithelial cells 2. ATOH8 also confers tumor cell vulnerability to ferroptosis by suppressing stearoyl-CoA desaturase (SCD) transcription in collaboration with TCF3 3. In kidney disease, ATOH8 plays a protective role in podocytes, where its loss activates TGF-β signaling and exacerbates glomerulosclerosis 4. The gene is involved in endometrial stromal cell decidualization, where BMP2 and cAMP regulate its expression, and ATOH8 subsequently controls the WNT/FZD-FOXO1 pathway 5. ATOH8 expression is frequently downregulated in cancers, with hypermethylation occurring in approximately 12% of lung cancer cases 2. Its mRNA stability is negatively regulated by FXR1, which promotes mRNA degradation in esophageal cancer 6.